-
PT-141 and Bremelanotide: Matching Sexual-Desire Claims to the Evidence
Learn what bremelanotide trials studied, why sexual desire and erectile function are different concerns, and what…
-
NAD+ Injections and Infusions: A Metabolism Study Is Not a Longevity Guarantee
Understand NAD+ injection and infusion claims, what metabolite studies measure, and why delivery method and patient…
-
Melanotan II and Tanning: Questions a Cosmetic Goal Should Not Hide
Examine Melanotan II tanning claims, the limits of small early studies, and why skin changes require…
-
MOTS-c and Tesamorelin: Why Metabolic Research Does Not Validate a Blend
Separate MOTS-c research from tesamorelin trial findings and learn why a combination needs evidence matching its…
-
MOTS-c and Exercise: Why an Exercise-Related Peptide Is Not an Exercise Replacement
Understand MOTS-c research, the distinction between natural exercise responses and administered products, and how to assess…
-
LL-37: What Human Wound Studies Mean for Broader Health Claims
Read LL-37 wound research in context, including differing trial results and why topical ulcer findings do…
-
LIPO-C and “Fat Metabolism”: What That Phrase Leaves Unanswered
Understand LIPO-C claims, why normal nutrient roles do not prove fat loss from injections, and what…
-
LIPO-B Injections: Separating Vitamin Support From Weight-Loss Promises
Learn what to ask about LIPO-B ingredients, B12 status, energy claims, and evidence for the exact…
-
Kisspeptin and Sexual Desire: What Early Human Studies Can—and Cannot—Tell You
Explore kisspeptin studies in sexual desire, the importance of the exact formulation, and questions for a…
-
IGF-LR3 Is Not Ordinary IGF-1: How to Read the Evidence Carefully
Understand why IGF-LR3 should not inherit claims from other IGF-1 products, and how molecular identity, study…
-
Subscribe
Subscribed
Have a WordPress.com account? Log in now.
